ABSTRACT
Objective To observe the clinical efficacy of acupuncture at the nine acupoints on nape in treating vertebrobasilar ischemia (VBI). Methods Totally 100 VBI patients were randomized into a treatment group and a control group, 50 in each group. The treatment group was intervened by acupuncture at Fengfu (GV 16), Fengchi (GB 20), Wangu (GB 12), Tianzhu (BL 10), and Jiaji (EX-B 2, C3);while the control group was by oral administration of Nimodipine tablets. The parameters in Transcranial Doppler (TCD) and Dizziness Assessment Rating Scale (ADRS) were observed before and after intervention, and the clinical efficacies were compared. Results The TCD parameters were significantly changed in the treatment group after intervention (P<0.05). The TCD parameters [Vs (RVA), Vd (BA, LVA), Vm (BA, RVA), PI (BA)] were significantly changed in the control group after intervention (P<0.05). After intervention, there were significant differences in comparing the TCD parameters [Vs (BA, LVA, RVA), Vd (BA, RVA), Vm (BA, LVA), PI (BA)] between the two groups (P<0.05). The DARS average scores were significantly changed in both groups after 7-day treatment (P<0.01). The DARS average scores after the whole intervention were significantly different from that after 7-day treatment in both groups (P<0.01). There were significant differences in comparing the DARS average scores between the two groups after 7-day intervention and after the whole intervention (P<0.01). The recovery-markedly effective rate and total effective rate were respectively 76.0%and 98.0%in the treatment group versus 44.0%and 96.0%in the control group, and there was a significant difference in comparing the recovery-markedly effective rate (P<0.05). Conclusions Acupuncture at the nine nape acupoints is an effective method in treating VBI.
ABSTRACT
No abstract available.
Subject(s)
Basilar Artery , Brain Infarction , Brain Stem , Endovascular Procedures , Stroke , Thrombolytic Therapy , Vertebrobasilar InsufficiencyABSTRACT
Objective To explore the effects of Xuan Yun Ning on the plasma endothelin in pafients with vertebrobasilar ischemia.Methods 60 cases of vertebrobasila ischemia were randomly recruited into a treatment group and a control group,with 30 cases in each group.The control group was treated with Nimodipin,and the treatment group was treated with Xuan Yun Ning plus Nimodipin.Another 30 healthy persons whose age is more than 40 years were recruited for a healthy control group without any treatment The alterations of plasma endothelin were measured by radiation immunological test in the treatment group,the control group,and the healthy control group.Results The elevated plasma endothelin was significantly decreased in treatment group than the control group and the healthy control group(P＜0.05).Conclusion Xuan Yun Ning improves the blood volume by lowering the level of plasma endothelin and thus treats patients with vertebrobasilar ischemia.
ABSTRACT
OBJECTIVE:To evaluate the therapeutic effects and cost-effectiveness of 3 therapeutic regimens in the treatment of vertebrobasilar ischemia. METHODS: 90 cases with vertebrobasilar ischemia were randomly divided into 3 groups: Group A were assigned to receive buflomedil+Flunarizine, Group B to receive Shuxuening + Flunarizine and Group C to receive compound Compound Danshen + Flunarizine. The curative effects and the cost-effectiveness of the 3 Groups after 14-day treatment were analyzed comparatively. RESULTS: The total costs for Group A, B and C were 1 705.06 yuan,2 876.30 yuan and 1 117.34 yuan, respectively; the effective rates were 93.75%, 92.86% and 70.00%, respectively; the cost-effectiveness ratios were 1 818.73, 3 097.46 and 1 596.20, respectively. As compared with Group C, the incremental costs-effectiveness ratios for Group A and Group B were 2 474.61 and 7 694.49, respectively. CONCLUSION: Group A is more preferable among the 3 therapeutic regimens in terms of cost-effectiveness.